Supplementary file 1_Efficacy of Bifidobacterium lactis BLa80 in preventing early childhoo
by Ke Chen·Updated 8d ago
3.8 MB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
360 formula-fed infants and children under 3 years old with elevated allergy risk participated in a randomized, double-blind, placebo-controlled trial. The dataset likely contains results from a 180-day intervention assessing eczema incidence, respiratory infections, gut microbiota composition, and fecal immune markers. Author Ke Chen published the data on figshare under a CC-BY-4.0 license, with a last update in May 2026.
Use Cases
Analyze the efficacy of Bifidobacterium lactis BLa80 in reducing eczema incidence based on the reported 27.6% vs. 69.5% incidence rates.
Investigate correlations between gut microbiome composition and clinical outcomes based on 16S rRNA sequencing and KEGG pathway analysis mentioned in the description.
Model the relationship between fecal immune markers like secretory IgA and calprotectin and symptom burden for upper respiratory tract infections.
Study the enrichment of specific beneficial taxa such as Akkermansia and Fusicatenibacter in relation to probiotic supplementation.
Strengths
Data originates from a randomized, double-blind, placebo-controlled trial with 360 participants, a robust study design.
Includes multiple outcome measures: primary (eczema incidence), secondary (respiratory infections), and exploratory (microbiota, immune markers).
Clinical trial is registered (ChiCTR2300074956), providing a traceable reference.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment for certain analyses.
The 3.8 MB file size suggests the dataset is relatively small, potentially limiting the scope of analysis.
Provenance
Source
figshare, author Ke Chen.
Collection Method
Data collected from a randomized, double-blind, placebo-controlled clinical trial.
Time Range
The trial intervention lasted 180 days; specific study dates are not provided.
Freshness
Last updated 2026-05-28 15:54:30; freshness should be verified.
Primary data file is in DOCX format, which may require conversion or specific tools for structured data extraction.